Insights
How we read this market
Notes on reimbursement, targeting technology, clinical infrastructure, and the policy questions that come with brain data.
Latest
ReadPolicySep 03, 2026
Brain Data and the Case for Entrustment
Brain data can serve as a proxy for emotional state. That makes it the most sensitive category of personal data, and the most valuable.
StrategyJun 30, 2026
Separating asset classes inside one fund is not a compromise between real estate and venture. It is what lets a firm own the whole pathway without concentrating the risk.
TechnologyMay 20, 2026
Most stimulation today is delivered to a location estimated from the outside of the skull. Imaging makes it possible to aim.
ResearchApr 02, 2026
Stimulation applied to the left dorsolateral prefrontal cortex produced durable improvements in abdominal pain — a result that points at a shared mechanism rather than a coincidence.
MarketFeb 18, 2026
Category III CPT codes for targeted central nervous system neuromodulation changed the economics of a treatment that patients had been funding themselves.
Avano will advance the global practice of medicine
We work with limited partners, clinical institutions, and neurotechnology founders building toward the same thing. If that is you, we would like to hear from you.